BRIGHT PEAK

At Bright Peak we are using our world-class protein engineering capabilities to create the next-generation of multifunctional precision immunotherapies... Bright Peak's chemical protein synthesis technology was initially developed by our Founders Vijaya Pattabiraman and Jeffrey Bode at ETH Zürich and the company was seeded and launched by Versant Ventures at the firm's Ridgeline Discovery laboratories. Bright Peak is currently funded by leading healthcare investors and is co-located in Basel, Switzerland and San Diego, California... Bright Peak Therapeutics is a clinical-stage biotechnology company advancing a broad portfolio of "next-generation" multi-functional PD-1 inhibitors, integrating both novel and validated mechanisms.

Also known as: Bright Peak Therapeutics

Primary location: Switzerland United States